AGIOS PHARMACEUTICALS, INC.
AGIO
32 insider filings · Latest: Jun 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 3 9:13 PM | Tsveta MilanovaChief Commercial Officer | Sale | 2,868 | $28.96 | $83.1K | 41,591(D) | View → |
| Mar 2, 2026 | Mar 3 9:12 PM | Theodore James Washburn Jr.Principal Accounting Officer | Sale | 2,223 | $28.96 | $64.4K | 6,140(D) | View → |
| Mar 2, 2026 | Mar 2 9:10 PM | Goff Brian | Proposed Sale | 18,055 | $30.23 | $545.8K | — | View → |
| Mar 2, 2026 | Mar 2 9:09 PM | Burns James William | Proposed Sale | 5,218 | $30.23 | $157.7K | — | View → |
| Mar 2, 2026 | Mar 2 9:08 PM | Gheuens Sarah | Proposed Sale | 4,055 | $30.23 | $122.6K | — | View → |
| Mar 2, 2026 | Mar 2 9:06 PM | Jones Cecilia | Proposed Sale | 5,035 | $30.23 | $152.2K | — | View → |
| Mar 2, 2026 | Mar 2 9:05 PM | Milanova Tsveta | Proposed Sale | 2,868 | $30.23 | $86.7K | — | View → |
| Jan 5, 2026 | Jan 5 9:05 PM | Milanova Tsveta | Proposed Sale | 2,872 | $27.22 | $78.2K | — | View → |
| Dec 30, 2025 | Dec 30 9:20 PM | Goff Brian | Proposed Sale | 18,703 | $27.16 | $508.0K | — | View → |
| Dec 30, 2025 | Dec 30 9:18 PM | Gheuens Sarah | Proposed Sale | 2,932 | $27.16 | $79.6K | — | View → |
| Dec 30, 2025 | Dec 30 9:16 PM | Jones Cecilia | Proposed Sale | 2,932 | $27.16 | $79.6K | — | View → |
| Dec 30, 2025 | Dec 30 9:13 PM | Milanova Tsveta | Proposed Sale | 2,932 | $27.16 | $79.6K | — | View → |
| Dec 30, 2025 | Dec 30 9:11 PM | Burns James William | Proposed Sale | 2,932 | $27.16 | $79.6K | — | View → |
| Nov 11, 2025 | Nov 12 3:35 PM | SARAH GHEUENS | Proposed Sale | 2,454 | $43.78 | $107.4K | — | View → |
| Oct 30, 2025 | Oct 30 9:02 PM | SARAH GHEUENS | Proposed Sale | 200 | $43.81 | $8.8K | — | View → |
| Oct 27, 2025 | Oct 27 8:32 PM | SARAH GHEUENS | Proposed Sale | 3,302 | $43.92 | $145.0K | — | View → |
| Oct 8, 2025 | Oct 8 8:01 PM | DAVID SCADDEN | Proposed Sale | 200 | $41.00 | $8.2K | — | View → |
| Sep 30, 2025 | Sep 30 8:48 PM | DAVID SCADDEN | Proposed Sale | 200 | $40.00 | $8.0K | — | View → |
| Sep 26, 2025 | Sep 26 8:15 PM | Jones Cecilia | Proposed Sale | 3,651 | $36.77 | $134.2K | — | View → |
| Aug 27, 2025 | Aug 27 8:13 PM | DAVID T. SCADDEN | Proposed Sale | 200 | $40.00 | $8.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 3 9:17 PM | James William BurnsChief Legal Officer | Option Exercise | 17,586 | — | 7,839(D) | View → |
| Mar 1, 2026 | Mar 3 9:17 PM | James William BurnsChief Legal Officer | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:15 PM | Sarah GheuensChief Medical Officer | Option Exercise | 13,666 | — | 8,000(D) | View → |
| Mar 1, 2026 | Mar 3 9:15 PM | Sarah GheuensChief Medical Officer | Grant/Award | 88,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:14 PM | Cecilia JonesChief Financial Officer | Option Exercise | 16,969 | — | 10,607(D) | View → |
| Mar 1, 2026 | Mar 3 9:14 PM | Cecilia JonesChief Financial Officer | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:13 PM | Tsveta MilanovaChief Commercial Officer | Option Exercise | 9,666 | — | 8,000(D) | View → |
| Mar 1, 2026 | Mar 3 9:13 PM | Tsveta MilanovaChief Commercial Officer | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
| Mar 2, 2026 | Mar 3 9:12 PM | Theodore James Washburn Jr.Principal Accounting Officer | Option Exercise | 7,495 | — | 5,390(D) | View → |
| Mar 1, 2026 | Mar 3 9:12 PM | Theodore James Washburn Jr.Principal Accounting Officer | Grant/Award | 8,452 | — | 8,452(D) | View → |
| Mar 1, 2026 | Mar 3 9:11 PM | Krishnan ViswanadhanChief Corp Dev & Strategy | Grant/Award | 66,000 | $30.23 | 52,000(D) | View → |
← Previous
Page 3 of 3